首頁 > 市場調查報告書 > 醫療設備

導管心血管設備

市場調查報告書

商品編碼

1687622

周邊干預市場規模、佔有率及成長分析（按干預類型、設備類型、適應症、技術、最終用戶和地區）—2025 年至 2032 年行業預測

Peripheral Interventions Market Size, Share, and Growth Analysis, By Intervention Type (Atherectomy, Stent Implantation), By Device Type (Catheters, Stents), By Indication, By Technology, By End User, By Region - Industry Forecast 2025-2032

出版日期: 2025年03月20日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023 年外周干預市場規模價值 102 億美元，預計將從 2024 年的 111.3 億美元成長到 2032 年的 223.4 億美元，預測期內（2025-2032 年）的複合年成長率為 9.1%。

高血壓、糖尿病、肥胖、吸煙和高碳水化合物飲食等因素導致心血管疾病（CVD）的流行，這是周邊干預需求的主要促進因素。為了應對這項健康挑戰，世界各地，尤其是新興市場的導管實驗室數量顯著增加，專門從事該領域的醫療保健專業人員的數量也相應增加。導管室在心血管疾病的診斷和治療中變得越來越重要，其存在正在擴大，特別是在開發中國家。支持介入心臟病學以外多種程序的混合實驗室的出現凸顯了該行業的技術創新。例如，印度的心導管實驗室數量最近增加了一倍多，同時血管成形術的數量也激增，預計這將推動全球醫療保健支出和周邊介入服務的進一步成長。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司詳情
- 產品系列分析
- 公司分部佔有率分析
- 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

Medtronic plc（Ireland）
Abbott Laboratories（USA）
Boston Scientific Corporation（USA）
Becton, Dickinson and Company（BD）（USA）
Philips（Netherlands）
Terumo Corporation（Japan）
Cook Medical（USA）
Cardinal Health, Inc.（USA）
B. Braun Melsungen AG（Germany）
Getinge AB（Sweden）
Merit Medical Systems, Inc.（USA）
BIOTRONIK SE & Co. KG（Germany）
Endologix, Inc.（USA）
ArtVentive Medical Group, Inc.（USA）
Inari Medical, Inc.（USA）
Bentley InnoMed GmbH（Germany）
Gore Medical（USA）
MicroPort Scientific Corporation（China）

結論和建議

簡介目錄

Product Code: SQMIG35D2214

Peripheral Interventions Market size was valued at USD 10.2 billion in 2023 and is poised to grow from USD 11.13 billion in 2024 to USD 22.34 billion by 2032, growing at a CAGR of 9.1% during the forecast period (2025-2032).

The rising incidence of cardiovascular disorders (CVD) is significantly driving demand for peripheral interventions, fueled by factors like hypertension, diabetes, obesity, smoking, and high-carb diets. To address this health issue, there is a notable increase in catheterization laboratories (cath labs) globally, particularly in emerging markets, accompanied by a growing number of healthcare professionals specializing in this field. Cath labs are becoming essential for diagnosing and treating CVD, and their presence is expanding, especially in developing nations. The advent of hybrid labs, which support various procedures beyond cardiovascular interventions, highlights industry innovation. For instance, India's cath labs have more than doubled recently, coinciding with a surge in angioplasties, thereby boosting global healthcare spending and anticipating further growth in peripheral intervention services.

Top-down and bottom-up approaches were used to estimate and validate the size of the Peripheral Interventions market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Peripheral Interventions Market Segments Analysis

Global Peripheral Interventions Market is segmented by Intervention Type, Device Type, Indication, Technology, End User and region. Based on Intervention Type, the market is segmented into Atherectomy, Stent Implantation, Angioplasty, Thrombectomy and Embolization. Based on Device Type, the market is segmented into Catheters, Stents, Guide Wires, Balloons and Embolic Coils. Based on Indication, the market is segmented into Coronary Artery Disease, Stroke, Peripheral Arterial Disease, Renal Artery Stenosis and Carotid Artery Stenosis. Based on Technology, the market is segmented into Drug-Eluting Stents, Balloon-Expandable Stents, Self-Expanding Stents, Rotational Atherectomy and Directional Atherectomy. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, Clinics and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Peripheral Interventions Market

The increasing prevalence of cardiovascular diseases, particularly peripheral artery disease (PAD), is a significant factor fueling the demand for peripheral intervention solutions. This surge in cases of cardiovascular conditions can largely be linked to risk factors such as hypertension, diabetes, obesity, and a lack of physical activity. As more individuals face these health challenges, there is an urgent need for effective peripheral therapies that address these issues. Consequently, healthcare providers and manufacturers are responding to this growing demand by developing and offering innovative treatment options tailored to manage and mitigate the effects of these cardiovascular disorders.

Restraints in the Peripheral Interventions Market

The Peripheral Interventions market faces significant limitations due to the high costs associated with these treatments, which can be a barrier for many individuals seeking care. In particular, those living in developed regions may find that expensive healthcare options hinder their access to necessary procedures. The financial strain imposed by these interventions can deter patients from pursuing them, ultimately affecting the overall growth and accessibility of the market. Consequently, the high cost of peripheral interventions remains a critical restraint that impacts patient choices and the market's expansion potential in various geographic areas.

Market Trends of the Peripheral Interventions Market

The Peripheral Interventions market is experiencing a significant trend towards the establishment of heterogeneous catheterization labs that integrate various invasive interventional treatments, including cardiac, vascular, neurological, and electrophysiological procedures. These hybrid facilities are gaining traction due to their flexibility, which allows healthcare providers to streamline operations and enhance patient outcomes by combining different specialties under one roof. This trend is driven by the demand for minimally invasive treatment options and the need for efficient patient management, propelling market growth. As technology advances and the focus shifts to personalized care, the hybridization of catheterization labs is set to revolutionize the landscape of peripheral interventions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Peripheral Interventions Market Size by Intervention Type & CAGR (2025-2032)

Market Overview
Atherectomy
Stent Implantation
Angioplasty
Thrombectomy
Embolization

Global Peripheral Interventions Market Size by Device Type & CAGR (2025-2032)

Market Overview
Catheters
Stents
Guide Wires
Balloons
Embolic Coils

Global Peripheral Interventions Market Size by Indication & CAGR (2025-2032)

Market Overview
Coronary Artery Disease
Stroke
Peripheral Arterial Disease
Renal Artery Stenosis
Carotid Artery Stenosis

Global Peripheral Interventions Market Size by Technology & CAGR (2025-2032)

Market Overview
Drug-Eluting Stents
Balloon-Expandable Stents
Self-Expanding Stents
Rotational Atherectomy
Directional Atherectomy

Global Peripheral Interventions Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals
Ambulatory Surgical Centers
Clinics
Research Institutes

Global Peripheral Interventions Market Size & CAGR (2025-2032)

North America (Intervention Type, Device Type, Indication, Technology, End User)
- US
- Canada
Europe (Intervention Type, Device Type, Indication, Technology, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Intervention Type, Device Type, Indication, Technology, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Intervention Type, Device Type, Indication, Technology, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Intervention Type, Device Type, Indication, Technology, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Getinge AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIOTRONIK SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endologix, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ArtVentive Medical Group, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inari Medical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bentley InnoMed GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gore Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments